Genomics Sequencing & Testing

Since 1992, Cerba Research/Healthcare has pioneered the art of human genetic testing, Cerba Healthcare builds the start of the art in human genetic testing by being the first laboratory in Europe to introduce Genetic testing.

Thanks to this experience, we are able to collaborate with the life science community to provide the most suitable genomic service and enhance the power of your genetic material.

Cerba Research can work with you to select the most suitable platform and assay to reach your project expectations.

Our Genomics Solutions

DNA/RNA Extraction

Discover our solution for your DNA/RNA extractions needs.

Next Generation Sequencing Capabilities

Cerba Research is able to propose fit-for-purpose Next Generation Sequencing capabilities, by means of numerous comprehensive broad panel assays available for analysis, and more.

Next Generation Sequencing For Solid Tumors

Our experienced scientific team provides a flexible, customizable and responsive approach to your NGS solid tumor clinical trials.

Next Generation Sequencing For Hematological Malignancies

Cerba Research offers state-of-the-art genomic technologies to obtain the essential dataset of your samples dedicated to hematological malignancies.

Lab,Technician,Or,Medical,Scientist,Wearing,Protective,Suit,face,Maks,And

Next Generation Sequencing For Liquid Biopsies

Cerba Research is proud to be at the forefront of cancer early detection thanks to our liquid biopsies (ctDNA) NGS solutions.

Genomic For Infectious Diseases

Cerba Research can support your infectious disease trial with our genomic capabilities.

Constitutional Genomic

We are happy to propose whole exome/genome sequencing including SNP, CNV and indel.

Custom Assay Development

We are able to provide custom laboratory assay, panel design and medical grade reports.

55

Specialized Technicians

7

Geneticists

25 000

Karyotypes/year

Our Genomics Landscape

Discover the diversity of our genomics platform, tailored for your project

Next Generation Sequencing

Single nucleotide variants (SNV)
• Insertion and deletions (numerous broad panel assays aligned with guidelines)
• Copy number variations (CNV)
• Gene fusions
• Tumor mutational burden (TMB)
• Microsatellite instability (MSI)
• Minimal residual disease (MRD) on demand
• Homologous recombination deficiency (HRD)
• Somatic hypermutation

qPCR

Cerba Research’s family of qPCR solutions is designed to simplify your process and expedite your clinical trial results and to help you answer important clinical questions faster and easier. For example, we can detect EGFR alterations by means of FFPE and ctDNA using qPCR instruments.

dd (Digital Droplet) PCR

Cerba Research also owns droplet digital (ddPCR) instruments. ddPCR is a method that can perform digital PCR which is based on water-oil emulsion droplet technique. ddPCR may also offer a robust mutation detection sensitivity (0.05-0.1%).

miRNA analysis

TCR Sequencing

The TCR repertoire, that is, the diverse collection of clonotypes in an organism, plays an important role in shaping the immune function, health, and disease progression. At Cerba Research, we are able to perform TCR seq by means of NGS with various already existing and validated kits.

Nanostring Assay

Nanostring is an amplification-free technology that measures nucleic acid content by counting molecules directly. It enables researchers to analyze and interpret differential gene expression results and benefit from a solution for multiplex analysis of 800+ targets.

Whole Exome / Genome Sequencing

Cerba Research is proud to propose whole exome and whole genome sequencing capabilities, including coding, non-coding and mitochondrial DNA.

We can also help you discover novel genomic variants (structural, single nucleotide, insertion-deletion, copy number) and previously unknown variants identification for future targeted studies.

Finally, we can guide you through your whole exome sequencing journey with 22,000 genes and clinical exome sequencing capabilities with 6,000 genes, including SNPs, CNVs, and indels.

B-cell Receptor Sequencing

BCR sequencing explores the diversity of the B-cell receptor repertoire through sequencing. Cerba Research is committed to providing comprehensive solutions with the best quality to advance your global cell therapy trial. We already have experience with already existing and validated kits for your BCR sequencing needs.